“I am very impressed with the thoroughness of the analysis. I hope to steer more data your way soon. Again, thank you for undertaking this at a small cost. It is much appreciated.”
“Thanks for getting this back so quickly, and for the thoroughness of the design and report. We look forward to working with you again!”
“A pleasure to work with. Concise and detailed report for our 3D cell assay. We’ll have more projects your way soon!”
“Extremely impressive work, thanks for getting this back to us so quickly. I really appreciate the detailed analysis.”
Spotlight
NASH 3D Cell Culture Assays
Our expertise in 3D cell culture models and quantitative evaluation allows for an unparalleled evaluation of compounds which ameliorate the NASH continuum.
Biomarker Co-localization and Quantification
We perform quantitative analysis of distribution, colocalization and spatial relationships of biomarkers and cells detected in H&E, IF, multiplex IHC and ISH slides.
Tissue Analysis for Immuno-oncology
Automated analysis of the number, distribution, and infiltration of immune cell sub-types within tumor tissue specimens.
Featured Posts
Cell Painting – Molecular Imaging in Drug Discovery
Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide range of scientific disciplines including, but not limited to, biology, chemistry, and pharmacology. With the [...]
Cell-Subtype Selection in the Creation of a 3D Liver Fibrosis Model
Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models using TGFβ1 can induce a fibrosis-like effect whereby the stellate population is activated and begins [...]
Bruker and Visikol Partner to Launch Light-Sheet Imaging Services
Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi SPIM CS Light-Sheet Microscopy platform to provide its clients with an even wider range of [...]
Visikol Expands Product Portfolio with New Tissue Slicers
Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and kits over five years ago for 3D tissue imaging which have now been used by [...]
Visikol named to Pharma Tech Outlook’s Top Emerging Pharma Outsourcing Companies of 2021
Pharma Tech Outlook acknowledges Visikol and how the company is leveraging its advanced imaging and 3D cell culture solutions to provide its Clients with best-in-class drug discovery solutions. In this post, Visikol Chief Science [...]
Using Noise Reduction Methods in ImageJ to Produce High Quality Data
After completing the imaging process for your desired biological model, you may find that some of your images have artifacts that are likely not a part of the true signal you’re attempting to extract. [...]
